Clinical Trial Update: Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials evaluating emixustat hydrochloride for geographic atrophy have completed, with safety and efficacy assessed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Geographic Atrophy

Drugs mentioned

• Emixustat hydrochloride (emixustat hydrochloride)

Snippet

Sponsor: Kubota Vision Inc. | Conditions: Geographic Atrophy | Phase 2, Phase 3 | Status: COMPLETED